or Try an Advanced Search...

    Technical Analysis for SPRO - Spero Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 1.67 0.60% 0.01
    SPRO closed up 0.6 percent on Wednesday, May 8, 2024, on 35 percent of normal volume. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    Earnings due: May 15
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical SPRO trend table...
    Date Alert Name Type % Chg
    50 DMA Support Bullish 0.00%
    MACD Bullish Centerline Cross Bullish 0.00%
    Overbought Stochastic Strength 0.00%
    Narrow Range Bar Range Contraction 0.60%
    Overbought Stochastic Strength 0.60%
    Crossed Above 50 DMA Bullish 0.60%
    Narrow Range Bar Range Contraction 0.60%
    Stochastic Reached Overbought Strength 0.60%
    Gapped Up Strength 0.60%
    Overbought Stochastic Strength 0.60%
    Older End-of-Day Signals for SPRO ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 10 hours ago
    Up 1% about 10 hours ago
    50 DMA Support about 12 hours ago
    Fell Below 50 DMA about 12 hours ago
    60 Minute Opening Range Breakdown about 12 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SPRO Chart by TradingView
    Basic chart:

    Profile

    Spero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Bacterial Infections Veterinary Medicine Regulus Therapeutics Antimicrobial Resistance Drug Resistant Bacterial Infections Evolutionary Biology Multi Drug Resistant Bacterial Infections

    Is SPRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
    May 1 Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Apr 23 Spero Therapeutics Delivers On Game Plan To Create Shareholder Value
    Apr 16 14 Cheap Penny Stocks to Buy According to Analysts
    Mar 17 Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
    Mar 15 Spero Therapeutics files $300M mixed securities shelf
    Mar 15 Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript
    Mar 15 Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
    Mar 14 Q4 2023 Spero Therapeutics Inc Earnings Call
    Mar 13 Spero Therapeutics, Inc. (SPRO) Q4 2023 Earnings Call Transcript
    See more SPRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.948
    52 Week Low 0.99
    Average Volume 336,432
    200-Day Moving Average 1.40
    50-Day Moving Average 1.64
    20-Day Moving Average 1.53
    10-Day Moving Average 1.55
    Average True Range 0.08
    RSI (14) 60.00
    ADX 29.73
    +DI 22.59
    -DI 12.97
    Chandelier Exit (Long, 3 ATRs) 1.50
    Chandelier Exit (Short, 3 ATRs) 1.62
    Upper Bollinger Bands 1.73
    Lower Bollinger Band 1.32
    Percent B (%b) 0.85
    BandWidth 26.93
    MACD Line 0.00
    MACD Signal Line -0.03
    MACD Histogram 0.0308
    Fundamentals Value
    Market Cap 88.51 Million
    Num Shares 53 Million
    EPS 0.39
    Price-to-Earnings (P/E) Ratio 4.28
    Price-to-Sales 1.02
    Price-to-Book 1.35
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.76
    Resistance 3 (R3) 1.76 1.72 1.75
    Resistance 2 (R2) 1.72 1.70 1.73 1.74
    Resistance 1 (R1) 1.70 1.69 1.71 1.70 1.73
    Pivot Point 1.66 1.66 1.67 1.67 1.66
    Support 1 (S1) 1.64 1.64 1.65 1.64 1.61
    Support 2 (S2) 1.60 1.63 1.61 1.60
    Support 3 (S3) 1.58 1.60 1.60
    Support 4 (S4) 1.58